BioDelivery Sciences International, Inc.
BDSI
BDSI was delisted on the 22nd of March, 2022.
157 hedge funds and large institutions have $439M invested in BioDelivery Sciences International, Inc. in 2019 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 58 increasing their positions, 29 reducing their positions, and 10 closing their positions.
380% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 10
100% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 29
71% more capital invested
Capital invested by funds: $256M → $439M (+$182M)
32% more funds holding
Funds holding: 119 → 157 (+38)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
37% less call options, than puts
Call options by funds: $461K | Put options by funds: $737K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
+$10.6M |
| 2 |
BlackRock
New York
|
+$10.1M |
| 3 |
Two Sigma Investments
New York
|
+$8.7M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$7.83M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
-$26M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$10.9M |
| 3 |
DM
Deerfield Management
New York
|
-$3.44M |
| 4 |
PCM
Penn Capital Management
Philadelphia,
Pennsylvania
|
-$2.84M |
| 5 |
JGC
J. Goldman & Co
New York
|
-$2.48M |
BDSI Hedge Fund Activity: Q4 2019 in Review
157 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q4 2019, worth a combined $439M — up 71% from $256M a quarter earlier.
Buyers outnumbered sellers: 48 funds opened new BDSI positions and 10 closed out — a net gain of 38 holders — while 58 added to existing stakes and 29 trimmed.
The largest buyer was Systematic Financial Management, adding an estimated $10.6M. The largest seller was Avoro Capital Advisors, cutting an estimated $26M.
- 157 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q4 2019, up from 119 in Q3 2019.
- Funds reported $439M of BioDelivery Sciences International, Inc. stock for Q4 2019, up 71% quarter-over-quarter.
- 48 funds opened new BioDelivery Sciences International, Inc. positions in Q4 2019 and 10 closed out, a net change of +38 holders.
- The largest BioDelivery Sciences International, Inc. buyer in Q4 2019 was Systematic Financial Management, an estimated $10.6M added.
- The largest BioDelivery Sciences International, Inc. seller in Q4 2019 was Avoro Capital Advisors, an estimated $26M sold.
Based on aggregated 13F filings for Q4 2019.